Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum infection in man.
In the 5-year period 1973-1977, 43 patients infected with Dipylidium caninum and 43 patients infected with Hymenolepis diminuta were treated with Yomesan (niclosamide) in the dosages recommended by the Parasitic Disease Drug Service, Center for Disease Control. The first post-treatment stool specimen and 1-week and 3-month specimens were examined in 13 patients with D. caninum and 19 patients with H. diminuta. One hundred percent (13/13) of those with D. caninum and 89% (17/19) of those with H. diminuta had negative examinations at 3 months and were considered cured. Two patients with persistent H. diminuta were cured with a second course of drug without changing the dosage or time schedule. Four of these cases had been unresponsive to an initial course of quinacrine hydrochloride. Thus, niclosamide seems to be an effective, relatively nontoxic drug for the initial therapy of these cestode infections.
D000293:Adolescent; D000328:Adult; D002590:Cestode Infections / Q000188:drug therapy*; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy*; D009534:Niclosamide / Q000627:therapeutic use*
D009534:Niclosamide